GE HealthCare Technologies Inc.·4

May 19, 4:05 PM ET

Rackliffe Philip 4

Research Summary

AI-generated summary

Updated

GE HealthCare (GEHC) CEO Philip Rackliffe Receives 16,458 RSUs

What Happened

  • Philip Rackliffe, CEO (AIS) of GE HealthCare Technologies Inc. (GEHC), was granted 16,458 restricted stock units (RSUs) on May 15, 2026. The award is reported as an acquisition at $0.00 per unit (standard for equity awards reported as "A" — award/grant). The filing does not state a market-dollar value for the grant.

Key Details

  • Transaction date: 2026-05-15; Form 4 filed: 2026-05-19 (filed within the reporting deadline).
  • Grant: 16,458 RSUs; reported acquisition price: $0.00 per unit.
  • Vesting (per footnote): 50% vest on May 15, 2028; 50% vest on May 15, 2029.
  • Each RSU equals the right to receive one share of GE HealthCare common stock at settlement (per footnote).
  • Shares owned after the transaction: not specified in the information provided in this filing.
  • Transaction code: A (award/grant).

Context

  • RSUs are a form of compensation that convert into actual shares only when they vest; they are not immediately tradable stock. This grant is a routine equity compensation event rather than an open‑market purchase or sale and should be viewed accordingly. The filing was submitted within the normal Form 4 deadline.